Breath Therapeutics' Series A Round

Breath Therapeutics raised a round of funding on March 08, 2017.

Breath Therapeutics is advancing an inhalation therapy for treatment of Bronchiolitis Obliterans Syndrome (BOS), a lethal orphan respiratory disease, mainly affecting lung transplant patients.…

Articles about Breath Therapeutics' Series A Round: